These receptors then bind to the costimulatory ligands CD80, CD86, PD-L1, and Programmed Death-Ligand 2 (PD-L2), which are expressed by tumor cells, regulatory T cells (Tregs), myeloid cells, and antigen-presenting cells (APCs). This evidence concerns the gene PDCD1LG2 and neoplasm.